Chromatin control of human cytomegalovirus infection

ABSTRACT Human cytomegalovirus (HCMV) is a betaherpesvirus that establishes lifelong infection in its host and can cause severe comorbidities in individuals with suppressed or compromised immune systems. The lifecycle of HCMV consists of lytic and latent phases, largely dependent upon the cell type...

Full description

Bibliographic Details
Main Authors: Stephen M. Matthews, Ian J. Groves, Christine M. O'Connor
Format: Article
Language:English
Published: American Society for Microbiology 2023-08-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mbio.00326-23
_version_ 1827855172480532480
author Stephen M. Matthews
Ian J. Groves
Christine M. O'Connor
author_facet Stephen M. Matthews
Ian J. Groves
Christine M. O'Connor
author_sort Stephen M. Matthews
collection DOAJ
description ABSTRACT Human cytomegalovirus (HCMV) is a betaherpesvirus that establishes lifelong infection in its host and can cause severe comorbidities in individuals with suppressed or compromised immune systems. The lifecycle of HCMV consists of lytic and latent phases, largely dependent upon the cell type infected and whether transcription from the major immediate early locus can ensue. Control of this locus, which acts as a critical “switch” region from where the lytic gene expression cascade originates, as well as regulation of the additional ~235 kilobases of virus genome, occurs through chromatinization with cellular histone proteins after infection. Upon infection of a host cell, an initial intrinsic antiviral response represses gene expression from the incoming genome, which is relieved in permissive cells by viral and host factors in concert. Latency is established in a subset of hematopoietic cells, during which viral transcription is largely repressed while the genome is maintained. As these latently infected cells differentiate, the cellular milieu and epigenetic modifications change, giving rise to the initial stages of virus reactivation from latency. Thus, throughout the cycle of infection, chromatinization, chromatin modifiers, and the recruitment of specific transcription factors influence the expression of genes from the HCMV genome. In this review, we discuss epigenetic regulation of the HCMV genome during the different phases of infection, with an emphasis on recent reports that add to our current perspective.
first_indexed 2024-03-12T11:41:17Z
format Article
id doaj.art-1baa590fe0aa4c9890996d03c17d6e98
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-03-12T11:41:17Z
publishDate 2023-08-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-1baa590fe0aa4c9890996d03c17d6e982023-08-31T15:04:20ZengAmerican Society for MicrobiologymBio2150-75112023-08-0114410.1128/mbio.00326-23Chromatin control of human cytomegalovirus infectionStephen M. Matthews0Ian J. Groves1Christine M. O'Connor2Infection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio, USAInfection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio, USAInfection Biology, Global Center for Pathogen and Human Health Research, Lerner Research Institute, Cleveland Clinic , Cleveland, Ohio, USAABSTRACT Human cytomegalovirus (HCMV) is a betaherpesvirus that establishes lifelong infection in its host and can cause severe comorbidities in individuals with suppressed or compromised immune systems. The lifecycle of HCMV consists of lytic and latent phases, largely dependent upon the cell type infected and whether transcription from the major immediate early locus can ensue. Control of this locus, which acts as a critical “switch” region from where the lytic gene expression cascade originates, as well as regulation of the additional ~235 kilobases of virus genome, occurs through chromatinization with cellular histone proteins after infection. Upon infection of a host cell, an initial intrinsic antiviral response represses gene expression from the incoming genome, which is relieved in permissive cells by viral and host factors in concert. Latency is established in a subset of hematopoietic cells, during which viral transcription is largely repressed while the genome is maintained. As these latently infected cells differentiate, the cellular milieu and epigenetic modifications change, giving rise to the initial stages of virus reactivation from latency. Thus, throughout the cycle of infection, chromatinization, chromatin modifiers, and the recruitment of specific transcription factors influence the expression of genes from the HCMV genome. In this review, we discuss epigenetic regulation of the HCMV genome during the different phases of infection, with an emphasis on recent reports that add to our current perspective.https://journals.asm.org/doi/10.1128/mbio.00326-23herpesvirusHHVepigeneticschromatincytomegalovirusCMV
spellingShingle Stephen M. Matthews
Ian J. Groves
Christine M. O'Connor
Chromatin control of human cytomegalovirus infection
mBio
herpesvirus
HHV
epigenetics
chromatin
cytomegalovirus
CMV
title Chromatin control of human cytomegalovirus infection
title_full Chromatin control of human cytomegalovirus infection
title_fullStr Chromatin control of human cytomegalovirus infection
title_full_unstemmed Chromatin control of human cytomegalovirus infection
title_short Chromatin control of human cytomegalovirus infection
title_sort chromatin control of human cytomegalovirus infection
topic herpesvirus
HHV
epigenetics
chromatin
cytomegalovirus
CMV
url https://journals.asm.org/doi/10.1128/mbio.00326-23
work_keys_str_mv AT stephenmmatthews chromatincontrolofhumancytomegalovirusinfection
AT ianjgroves chromatincontrolofhumancytomegalovirusinfection
AT christinemoconnor chromatincontrolofhumancytomegalovirusinfection